Saliva Testing Shows Promise for Faster, More Accessible Tuberculosis Diagnosis

Rapid and accurate tuberculosis (TB) diagnosis remains a critical global health challenge, particularly for individuals who have difficulty producing sputum—the traditional sample used for testing. New research indicates that analyzing saliva offers a highly accurate, non-invasive alternative to traditional methods, potentially improving TB detection rates and access to care. A recent study published in Clinical Infectious Diseases demonstrates that molecular testing of saliva is more sensitive than oral swabs for diagnosing pulmonary tuberculosis.

The Challenge of Traditional TB Diagnosis

Sputum analysis has long been the gold standard for diagnosing pulmonary TB. However, obtaining adequate sputum samples can be difficult for several reasons. Children, individuals with HIV, those with asymptomatic infections, and patients experiencing a dry cough may struggle to produce enough sputum for accurate testing. Sputum collection requires stringent airborne infection control protocols to prevent the spread of the disease.

Study Details and Findings

Researchers conducted a nested case-control study in Colombia between July 2023 and August 2024, involving 648 participants. The study compared the diagnostic performance of molecular testing on saliva and oral swabs against sputum culture, considered the definitive diagnostic method. Participants provided sputum, saliva, and oral swab samples.

The results showed that saliva testing achieved a sensitivity of 90.5% (95% confidence interval [CI], 82.8-95.6) and a specificity of 95.8% (95% CI, 89.6-98.8). Oral swabs had a sensitivity of 71.6% (95% CI, 61.4-80.4) and a specificity of 99% (95% CI, 94.3-100). Saliva sensitivity was 18.9% higher than that of oral swabs (P < .001), though the difference in specificity was not statistically significant (P = .25).¹

Why Saliva Testing is a Significant Advancement

The high sensitivity of saliva testing—exceeding the World Health Organization’s target of ≥80% for a low-complexity, nonsputum TB diagnostic test—is a major step forward. Saliva and swab collection were also highly acceptable to participants, with over 95% reporting a positive experience. This ease of collection, combined with the accuracy of the results, suggests that saliva testing could significantly improve TB case finding, particularly in settings where sputum collection is challenging.

Implications for TB Control

The findings support the use of saliva as a practical and accurate alternative specimen for TB diagnosis. This could lead to:

• Increased microbiological confirmation of TB cases.
• Improved case finding in both clinical and community settings.
• Reduced reliance on invasive sputum collection procedures.
• More accessible TB testing for vulnerable populations.

Future Directions

While the results are promising, further research is needed to validate these findings in larger, more diverse populations. Additional studies should explore the optimal methods for saliva collection, storage, and processing to ensure consistent and reliable results. Continued innovation in molecular diagnostic techniques will also be crucial for improving TB detection and control efforts worldwide.

²